Researchers strive to optimise preclinical insight while keeping animal use to a minimum, which is why dogs and NHPs are often chosen: their size supports repeated sampling, and their physiology is close enough to human to make the data worth reading. That closeness brings complications, since macaques and beagles each carry their own haematological and biochemical habits. The points below recur across Toxicology programmes in these two species.
1. Pre-Trial Data
Regular pre-trial data collection helps track changes over time, helps animals adapt to procedures, and identifies abnormal health conditions. Parameters such as red blood cell (RBC) count, neutrophil counts, and liver enzyme activity serve as indicators here. Excluding animals with abnormal parameters improves data interpretation.
2. Trial Design Variables
Blood sampling for pharmacokinetics/pharmacodynamics (PK/PD) studies is routine, but it can shift parameters such as RBC count and muscle enzyme activity. Sampling conditions therefore need to be standardised across animals and timepoints. Animal age, fasting, and route of administration also influence interpretation.
3. Red Blood Cells
Dogs and macaques have longer RBC lifespans than rodents, so a change in RBC mass takes longer to appear. Regional variation in crab-eating macaque RBCs affects counts, while splenic activity and mean corpuscular hemoglobin concentration (MCHC) levels influence interpretation and exclusion criteria.
4. White Blood Cells
Neutrophils and lymphocytes dominate peripheral blood white cell counts across species, but the proportions differ. Dogs typically show higher neutrophil counts (50-75% of WBCs) than macaques (25-50%), and both exceed rodents. The stronger neutrophil-mediated inflammatory response in dogs and macaques creates a specific difficulty: with limited animal numbers, a test-article effect is hard to separate from stress-induced leukocytosis. Transient lymphocytosis in healthy macaques points to viral infection in most cases.
5. Coagulation
Dogs have the shortest prothrombin time (PT), which demands high sensitivity from coagulation analysers. Some beagles lack coagulation factor VII, which slightly extends PT and is detectable in pre-trial data. Macaque activated partial thromboplastin time (APTT) ranges can double between reagent batches, which complicates interpretation across a long study. Deviations from standard procedures deserve attention: on a short baseline, a procedural slip looks like a treatment effect. Assay selection for these endpoints is set out on the Coagulation/Hemostasis Nonhuman Primates Disease Model page.
6. Liver Function
Alanine aminotransferase (ALT) remains the central marker for hepatocyte damage. Dogs show narrow ALT ranges (25-40 IU/L), which allows sensitive detection of changes induced by test substances. Macaque ALT ranges are broader and are influenced by age and by subclinical hepatitis A infection, and transient ALT elevations after infection complicate interpretation. Alkaline phosphatase (ALP) is sensitive in dogs but not in macaques for bile issues, whereas gamma-glutamyl transferase (γ-GT) is more sensitive and specific in macaques. Total bilirubin is unreliable in both species.
7. Kidney Function
Urea and creatinine levels in young beagles fall in a narrow range, which makes them sensitive indicators of renal effects in preclinical studies. Variation in macaques is wider. Urinalysis adds limited insight because collecting samples from uncooperative animals is difficult, and catheterisation can improve sample quality.
8. Muscle Injury
Assessing muscle damage is easier in dogs than in macaques. Incidental injuries from handling and procedures are common in macaques and show up as changes in creatine kinase (CK) activity. Cardiac troponins are better markers of myocardial injury in both species and surpass isoenzymes.
9. Carbohydrates, Proteins, and Lipids
Blood glucose in macaques is typically lower, but it rises with stress during collection, so a high value may indicate diabetes and warrants re-evaluation. Macaques also carry higher total protein and globulin concentrations, which fluctuate widely. Elevated globulin may suggest inflammation or infection.
10. Inorganic Substances and Electrolytes
Calcium and phosphate differences in macaques exceed those seen in dogs. Electrolyte concentrations in macaques can vary significantly, with high levels occasionally observed. Together these parameters give a view of organ function and of potential test-article effects.
Conclusion
Interpreting clinical pathology data from dog and macaque studies is shaped by small sample sizes, individual animal variability, and other study-related factors. Population differences remain important, yet individual animal variation may carry greater indicative significance than a group mean. Proper interpretation requires thorough evaluation of all available data, a working knowledge of species characteristics, and explicit consideration of how study design variables affect each parameter.
Two related discussions extend this one: Clinical Pathology Interpretation in Dogs And Nonhuman Primates in Preclinical Studies and Clinical Pathology Data Interpretation Challenges and Strategies in Preclinical Studies of Canines and Non-human Primates. Programmes that need these readouts generated alongside efficacy work can review the wider NHP Pharmacology platform.
